Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-22

Study Completion Date

2019-10-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Two Approaches in Enhancing the Efficacy of Inferior Alveolar Nerve Block During Treatment of Mandibular First Permanent Molars With Symptomatic Irreversible Pulpitis

NCT05427903

Pain, Procedural

UNKNOWN NA

Anesthetic Efficacy of 1,8mL and 3,6mL of Articaine in Inferior Alveolar Nerve Block in Irreversible Pulpitis

NCT02422823

Pulpitis

COMPLETED NA

Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration

NCT06119139

Symptomatic Irreversible Pulpitis

NOT_YET_RECRUITING NA

Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis

NCT04822415

Symptomatic Irreversible Pulpitis

COMPLETED NA

Effect of Emergency Pulpotomy Versus Pulp Extirpation on Anesthetic Efficacy in Endodontic Treatment of Acute Pulpitis

NCT04599244

Symptomatic Irreversible Pulpits

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In irreversible pulpitis of the mature permanent tooth, the enrolled patients receive endodontic medications (Eugenol or Articaine) in order to determine which one is the more efficient to control the pain.

These patients would have received the same medication without this study. That's why this is an obsevationnal study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulpitides Endodontic Inflammation Toothaches Operative Dentistry

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Articaïne

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

Intervention Type DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

Eugénol

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Intervention Type DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

Intervention Type DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient, major, affiliated to a social health insurance scheme
* Patient having agreed to participate in the study
* Urgent consultant patient for irreversible pulpitis
* Patient understanding French

Exclusion Criteria

* Refusal of the patient to participate in the study
* Impossibility of performing the surgical procedure
* Impossibility to give the subject information enlightened (difficulty of understanding ...)
* Subject under the protection of justice, or under guardianship
* General contraindication to endodontic treatment in 2 sessions (high risk of infectious endocarditis, for example)
* Chronic intake of analgesic drugs

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No